ESPE Abstracts (2016) 86 P-P2-715

ESPE2016 Poster Presentations Endocrinology and Multisystemic Diseases P2 (22 abstracts)

Management of Endocrine Complications of Thalassemia

Samira Aggoune

Pediatric Hematology-Oncology, Algier’s, Algeria

Background: β-thalassemia is the most common single gene disorder worldwide, in which hemoglobin β-chain production is decreased. Today, the life expectancy of thalassemic patients is increased because of a variety of treatment methods. However, osteoporosis and cardiac dysfunction remain frequent complications.

Objective and hypotheses: The aim of the study, was to analyze the diagnostic and prognostic role of ferritin for endocrinopathies and metabolic disorders in βT patients.

Method: This is a prospective study of previously chelated patients, and new patients followed at the pediatric hospital day since March 2010. Seventy-six βT patients were treated with different regimen of cheation. Sixty-three are under Deferasirox chelation. Data recorded included age, gender, haemoglobin and ferritin levels, biochemical and endocrine tests, liver, transfusion regimen, iron chelation, splenectomy, and bone mineralization by dual X-ray absorptiometry. The package of measures was made in a standard confidence interval of 95% and standard error consented risk is 5%.

Results: Thirty-seven (46.1%) males and 33 (53.9%) females were studied, with mean age of 106,57 months, mean haemoglobin 9.2±1.5 g/dL, median ferritin 895.40 ± 494.8; forty nine patients 49 had been transfused, occasionally (27/76, 35.5%); 19/76 patients had been splenectomized (25%); 63(83%) were on chelation therapy. Endocrinopathies were found in 10 patients: 08 hypogonadism, and one diabetes. Bone disease was observed in (14%) patients, osteoporosis in 3 /76 (7.9%), and osteopenia in 1/76 (1.5%). One fracture, six bone deformities and a hotbed of extra medullary hématopoeise, were objectived.

Conclusion: Iron chelation therapy in adequate dosage, early diagnosis and treatment of endocrine insufficiency and regular blood transfusions can help to achieve an optimal endocrine function.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts